Genomic Biomarkers to Improve Ulcerative Colitis Neoplasia Surveillance

No adequate means exist to identify the minority of ulcerative colitis (UC) patients destined to undergo neoplastic progression. Recognition of this subset would advance UC cancer surveillance by focusing the available management options onto the highest risk patients. Three different assays of geno...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Bronner, Mary P., O'Sullivan, Jacintha N., Rabinovitch, Peter S., Crispin, David A., Chen, Lu, Emond, Mary J., Rubin, Cyrus E., Brentnall, Teresa A.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society for Investigative Pathology 2008
Pynciau:
Regular Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2626395/
https://ncbi.nlm.nih.gov/pubmed/18988798
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2353/ajpath.2008.080250
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg